Presentation is loading. Please wait.

Presentation is loading. Please wait.

Preoperative screening for LVAD an TAH implantation

Similar presentations


Presentation on theme: "Preoperative screening for LVAD an TAH implantation"— Presentation transcript:

1 Preoperative screening for LVAD an TAH implantation
P. Leprince Institut de cardiologie Chirurgie Cardiovasculaire Groupe Hospitalier Pitié-Salpétrière Paris, France

2 Disclosure St Jude (Abott): Heartmate II Medtronic: HVAD, ECMO
Jarvik 2000 Syncardia

3 Pre operative assessment
Assess Illness severity Patient selection Optimize the sickest patients Define risk factor for surgery Right ventricle assessment Other organic and functional considerations Select appropriate device

4 Illness assessment for operative risk

5 Low: < 1.58 Mid: ,58 High: > 1.58

6

7

8 3 centers 101 patients Intermacs 1 (28) Intermacs 2-3 (49)
AJ Boyle et al. JHLT 2011, 30: 402

9 Intermacs 2016 report

10 BTB: HVAD 2012-2014 La Pitié 38 patients, 33 males 51± 12.5 y
12(31%) bridge to LVAD with peripheral ECMO 29 (76%) implanted on ECMO (vs CPB +valvular surgery) 7 (18%) peripheral ECMO + HVAD 17 (45%) percutaneous ECMO RVAD + HVAD  63 % RVAD support 71% hospital discharge

11 No ECMO ECMO pre N=26 N=12 No support ECMO Pc RVAD No support ECMO
31% N=5 19% N=13 50% N=6 50% N=2 16% N=4 33% 87% 60% 54% 83% 100% 75%

12

13

14

15 Infection screening and control

16 Right ventricular function
Echocardiography TAPSE S wave Strain Septal function LV/RV ratio

17 In case of RV dysfunction
Patient optimisation: inotropes, diuresis, CVVHD Biventricular or TAH support LVAD with temporary RVAD

18 Percutaneous temporary RVAD

19 Temporary percutaneous ECMO RVAD

20 Percutaneous temporary ECMO RVAD
N = 27 RVAD Timing (j) 2,1 ± 5,4 Duration (j) 12,9 ± 7,6 Devenir Death under RVAD 10 (37,0%) Weaning from RVAD 17 (63,0%) Transplantation 3 (11,1%) 6 months death 14 (51,8%) 50% 67% John n=12 14 d 21% 53% Bad-O n=45 21 j 64% Dang n=14 13 d

21 Other considerations Pulmonary function
Neurologic function +++Carotide art. assessment Valvular disease +++ aortic valve Arrhytmias Psychologic and psychiatric conditions Social conditions

22 Which device for which patient?
Center experience with multiple devices RV Function? Heart transplant candidate or DT patient? Body size: output vs space Surgical technic: sternotomy vs thoracotomy redo patient CPB vs ECMO vs off pump? Hemorrhagic risk

23 Requirement for biventricular support
Syncardia Carmat Double LVAD LVAD + temporary RVAD TAH with BiHVAD La Pitié

24 Which device for which patient?
Center experience with multiple devices RV Function? Heart transplant candidate or DT patient? Body size: output vs space Surgical technic: sternotomy vs thoracotomy redo patient CPB vs ECMO vs off pump? Hemorrhagic risk

25

26

27 Which device for which patient?
Center experience with multiple devices RV Function? Heart transplant candidate or DT patient? Body size: output vs space Surgical technic: sternotomy vs thoracotomy redo patient CPB vs ECMO vs off pump? Hemorrhagic risk

28

29 Biventricular Destination BTT HMIII LVAD

30 Спасибо Большое


Download ppt "Preoperative screening for LVAD an TAH implantation"

Similar presentations


Ads by Google